SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-21-003321
Filing Date
2021-03-22
Accepted
2021-03-22 17:03:36
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20210322xdefa14a.htm DEFA14A 40483
2 GRAPHIC tmb-20210322xdefa14a002.jpg GRAPHIC 96782
3 GRAPHIC tmb-20210322xdefa14a004.jpg GRAPHIC 22653
4 GRAPHIC tmb-20210322xdefa14a001.jpg GRAPHIC 71115
5 GRAPHIC tmb-20210322xdefa14a003.jpg GRAPHIC 41240
  Complete submission text file 0001558370-21-003321.txt   360992
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35565 | Film No.: 21761994
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences